Modified polynucleotides and uses thereof
The present disclosure provides modified substrates such as modified polynucleotides, proteins, antibodies, lipids, and cells and uses thereof. Method of generating the modified substrates, which may comprise cleavage of a cleavable group linking the substrate to a labeling moiety, are also provided herein.
1. A composition comprising a compound of Formula (I):
Formula (I)
or a salt or solvate thereof, wherein:
R A is an optionally substituted 5-12 membered ring system, wherein substituents on R A are independently selected from R 4 ;
R B comprises a nucleotide, a nucleotide analog, or a nucleoside, wherein each of the nucleotide, the nucleotide analog, and the nucleoside comprises a nucleobase, wherein the alkyne of Formula (I) is covalently linked to the nucleobase, wherein R B is optionally substituted with R 5 ;
R C is selected from optionally substituted C 1-6 alkyl, optionally substituted C 2-6 alkenyl, and optionally substituted C 2-6 alkynyl, or R C is absent, wherein substituents on R C are independently selected from R 6 ;
Y is —SH, —S(═O)H, —S(═O) 2 H, or —S(═O)(OH);
R 2 is selected from hydrogen, optionally substituted C 1-6 alkyl, optionally substituted C 2-6 alkenyl, optionally substituted C 2-6 alkynyl, optionally substituted C 3-6 cycloalkyl, and optionally substituted 3-6-membered heterocycloalkyl, wherein substituents on R 2 are independently selected from R 6 ;
each R 3 is independently selected from hydrogen, halogen, —CN, —OH, —OR 8 , —C(═O)R 8 , —CO 2 R 7 , —C(═O)N(R 7 ) 2 , —N(R 7 ) 2 , —NR 7 C(═O)R 7 , —NR 7 C(═O)N(R 7 ) 2 , —SR 7 , —S(═O)R 8 , —SO 2 R 8 , —SO 2 N(R 7 ) 2 , —NO 2 , optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkenyl, optionally substituted C 1 -C 6 alkynyl, optionally substituted monocyclic carbocycle, and optionally substituted monocyclic heterocycle, wherein optional substituents on C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkynyl, monocyclic carbocycle, and monocyclic heterocycle are independently selected from R 6 ;
or two R 3 are taken together with the atom to which they are attached to form an optionally substituted 3- to 6-membered heterocycle or carbocycle, wherein optional substituents on the 3- to 6-membered heterocycle or carbocycle are independently selected from R 6 ;
R 4 is selected from halogen, ═O, ═S, —CN, —OH, —OR 10 , —N(R 9 ) 2 , —C(═O)R 9 , —C(═O)OR 9 , —OC(═O)R 9 , —C(═O)N(R 9 ) 2 , —NR 9 C(═O)R 9 , —NR 9 C(═O)N(R 9 ) 2 , —OC(═O)N(R 9 ) 2 , —NR 9 C(═O)OR 9 , —OC(═O)OR 9 , —NR 9 SO 2 R 9 , —SR 9 , —S(═O)R 10 , —SO 2 R 10 , —SO 2 N(R 9 ) 2 , —NO 2 , optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 2 -C 6 alkynyl, an optionally substituted C 3 -C 10 carbocycle, and an optionally substituted 3-10-membered heterocycle, wherein substituents on R 4 are independently selected from R 6 ;
R 5 is selected from halogen, ═O, ═S, —CN, —OH, —OR 10 , —N(R 9 ) 2 , —C(═O)R 9 , —C(═O)OR 9 , —OC(═O)R 9 , —C(═O)N(R 9 ) 2 , —NR 9 C(═O)R 9 , —NR 9 C(═O)N(R 9 ) 2 , —OC(═O)N(R 9 ) 2 , —NR 9 C(═O)OR 9 , —OC(═O)OR 9 , —NR 9 SO 2 R 9 , —SR 9 , —S(═O)R 10 , —SO 2 R 10 , —SO 2 N(R 9 ) 2 , —NO 2 , optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 2 -C 6 alkynyl, an optionally substituted C 3 -C 10 carbocycle, and an optionally substituted 3-10-membered heterocycle, wherein substituents on R 5 are independently selected from R 6 ;
each R 6 is independently selected from halogen, ═O, ═S, —CN, —OH, —OR 10 , —N(R 9 ) 2 , —C(═O)R 9 , —C(═O)OR 9 , —OC(═O)R 9 , —C(═O)N(R 9 ) 2 , —NR 9 C(═O)R 9 , —NR 9 C(═O)N(R 9 ) 2 , —OC(═O)N(R 9 ) 2 , —NR 9 C(═O)OR 9 , —OC(═O)OR 9 , —SR 9 , —S(═O)R 10 , —SO 2 R 10 , —SO 2 N(R 9 ) 2 , —NO 2 , C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 aminoalkyl, C 3 -C 6 carbocycle, optionally substituted monophosphate, optionally substituted diphosphate, optionally substituted triphosphate, and 3- to 6-membered heterocycle;
each R 7 is independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 6 carbocycle, and optionally substituted 3-6-membered heterocycle, wherein optional substituents on the C 1 -C 6 alkyl, C 3 -C 6 carbocycle, and 3-6-membered heterocycle are independently selected from R 6 ;
or two R 7 are taken together with the atom(s) to which they are attached to form an optionally substituted 3- to 6-membered heterocycle, wherein optional substituents on the 3- to 6-membered heterocycle are independently selected from R 6 ;
each R 8 is independently selected from optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 6 carbocycle, and optionally substituted 3-6-membered heterocycle, wherein optional substituents on the C 1 -C 6 alkyl, C 3 -C 6 carbocycle, and 3-6-membered heterocycle are independently selected from R 6 ;
each R 9 is independently selected from hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 haloalkyl, C 3 -C 6 carbocycle, and 3- to 6-membered heterocycle;
or two R 9 on the same nitrogen atom are taken together with the nitrogen to which they are attached to form a 3- to 6-membered heterocycle;
each R 10 is independently selected from C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 haloalkyl, C 3 -C 6 carbocycle, and 3- to 6-membered heterocycle.
2. The composition of claim 1 , wherein the heteroatoms of R B are each N.
3. The composition of claim 2 , wherein R B is an optionally substituted pyrimidine, an optionally substituted 7H-pyrrolo[2,3-d]pyrimidine, or an optionally substituted purine.
4. The composition of claim 3 , wherein R B is substituted with at least one R 5 selected from an optionally substituted C 3 -C 10 carbocycle and an optionally substituted 3-10-membered heterocycle.
5. The composition of claim 3 , wherein R B comprises a blocked or terminated nucleotide or nucleotide analogue.
6. The composition of claim 1 , wherein R A is an optionally substituted 5-12 membered carbocyclic ring system.
7. The composition of claim 1 , wherein R A is an optionally substituted 5-12 membered heterocyclic ring system.
8. The composition of claim 1 , wherein the carbonyl in Formula (I) is connected to a carbon of R A .
9. The composition of claim 1 , wherein R A is an optionally substituted 5-12 membered bicyclic ring system.
10. The composition of claim 1 , wherein R A is substituted with at least 1 R 4 moiety.
11. The composition of claim 1 , wherein two R 3 are taken together with the atom to which they are attached to form an optionally substituted 3- to 6-membered heterocycle or carbocycle, wherein optional substituents on the 3- to 6-membered heterocycle or carbocycle are independently selected from R 6 .
12. The composition of claim 1 , wherein each R 4 is independently selected from halogen, —OH, —OR 10 , —N(R 9 ) 2 , —C(═O)R 9 , —C(═O)OR 9 , —OC(═O)R 9 , —C(═O)N(R 9 ) 2 , —NR 9 C(═O)R 9 , —NR 9 C(═O)N(R 9 ) 2 , —OC(═O)N(R 9 ) 2 , —NR 9 C(═O)OR 9 , —OC(═O)OR 9 , and optionally substituted C 1 -C 6 alkyl.
13. The composition of claim 1 , wherein Y is —SH.
14. The composition of claim 1 , wherein R C is absent.
15. The composition of claim 1 , wherein Y is —S(═O)H.
16. The composition of claim 1 , wherein Y is —S(═O)(OH).
17. The composition of claim 1 , wherein Y is —S(═O) 2 H.
18. The composition of claim 1 , wherein R A is a non-aromatic optionally substituted 5-12 membered ring system.
19. The composition of claim 1 , wherein the carbonyl and Y in Formula (I) are not on adjacent atoms of R A when R C is absent.
20. The composition of claim 1 , wherein the composition comprises an aqueous solution.